Just diagnosed with Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2), look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) hub →Overview
Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) is a rare condition. Also known as MPAL with t(9;22)(q34.1;q11.2); BCR-ABL1. Tomeko brings together the specialists, research, clinical trials, treatments and community for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:589534 · ICD-10 C92.7 · GARD 0022354
Find care for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
- Find a specialist or center for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
- Search recruiting clinical trials for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
- Open the interactive Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) hub — care near you, live trials & community
Authoritative references for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
Research & market landscape for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)
Following Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) — the real-world landscape behind the condition, in one place.
- Latest Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) research on PubMed ↗
- Recruiting Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) trials on ClinicalTrials.gov ↗
- Explore the Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) and every rare condition. See how Tomeko works with industry →
Common questions
What is Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)?
Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) is a rare condition. Also known as MPAL with t(9;22)(q34.1;q11.2); BCR-ABL1. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) together in one place.
What are the symptoms of Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)?
Symptoms of Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2).
How is Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) treated?
Treatment for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2), and review current options with them.
What causes Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) — is it genetic?
The cause and inheritance of Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) can explain what it means for you and your family.
I was just diagnosed with Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2), and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2), filtered to your area.
Are there clinical trials for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)?
Tomeko shows live, recruiting studies for Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2) from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for: